These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1843713

  • 1. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM, Terra Filho M, Cukier A, Santos SR, Verrastro C, Teixeira LR, Vargas FS.
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F, De Maria P, Ronchi E, Galimberti M.
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [Abstract] [Full Text] [Related]

  • 4. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
    Berezuk GP, Schondelmeyer SW, Seidenfeld JJ, Jones WN, Bootman JL.
    Clin Pharm; 1983 Mar; 2(2):129-34. PubMed ID: 6349905
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Salbutamol plus beclomethasone dipropionate versus theophylline for the prevention of methacholine-induced bronchospasm in patients with chronic bronchitis.
    Arossa W, Spinaci S, Testi R.
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):565-8. PubMed ID: 4066080
    [Abstract] [Full Text] [Related]

  • 8. Effect of theophylline in chronic obstructive lung disease.
    Umut S, Gemicioğlu B, Yildirim N, Barlas A, Ozüner Z.
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H, van der Straeten M, Pauwels R, Moerman E, Bogaert M.
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.
    Filuk RB, Easton PA, Anthonisen NR.
    Am Rev Respir Dis; 1985 Oct; 132(4):871-4. PubMed ID: 4051322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G, Cresci F, Lo Sapio P, Panuccio P.
    Int J Clin Pharmacol Res; 1987 Oct; 7(5):351-6. PubMed ID: 3667008
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
    Bossert J, Träger E.
    Fortschr Med; 1989 Apr 10; 107(11):255-8. PubMed ID: 2659475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.